Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

Cortes, J.; Di Cosimo, S.; Climent, M. A.; Cortes-Funes, H.; Lluch, A.; Gascon, P.; Mayordomo, J. I.; Gil, M.; Benavides, M.; Cirera, L.; Ojeda, B.; Rodriguez, C. A.; Trigo, J. M.; Vazquez, J.; Regueiro, P.; Dorado, J. F.; Baselga, J.

期刊名称Clinical Cancer Research
作者Cortes, J.; Di Cosimo, S.; Climent, M. A.; Cortes-Funes, H.; Lluch, A.; Gascon, P.; Mayordomo, J. I.; Gil, M.; Benavides, M.; Cirera, L.; Ojeda, B.; Rodriguez, C. A.; Trigo, J. M.; Vazquez, J.; Regueiro, P.; Dorado, J. F.; Baselga, J.
卷第15卷
期第1期
印刷ISSN1078-0432
电子ISSN1557-3265
文件大小272.44KB
发表时间2009-01-01
DOI10.1158/1078-0432.CCR-08-1113
页码307-314

发现好书期刊，享受阅读乐趣

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study